bind to a range of proteins with excellent specificity and
affinity.15,16,18À22 Nonetheless, there are urgent needs to
develop novel combinatorial libraries with new scaffolds
and functional groups in order to discover new classes of
ligands with enhanced specificity, affinity, and other biologi-
cal properties. This is because, with the presence of new side
chains and 3D structures, ligands with distinct functional
properites are expected to be identified.23
We have recently developed a new class of peptidomi-
metics termed “γ-AApeptides”, as they comprise N-acy-
lated-N-aminoethyl amino acid building blocks (Figure 1),
and chiral side chains are linked to the γ-carbon in the
building blocks.24 The other half of the side chains are
introduced onto the γ-AApeptide scaffold through acyla-
tion of the center N in each building block using a wide
variety of commercially available carboxylic acids, which
endow γ-AApeptides with a limitless potential for the
generation of chemically diverse libraries. In contrast to
R-peptides, each γ-AApeptide unit is comparable to a
dipeptide, and γ-AApeptides and R-peptides of the same
lengths project the same number of side chains. As such,
there is a strong potential to identify γ-AApeptides that
can mimic the structures and functions of R-peptides.
γ-AApeptides are potential antibiotic agents to combat
drug resistance by mimicking the mechanism of action of
natural antimicrobial peptides.27À29 Thus, it is envisioned
that there is great potential to identify γ-AApeptide-based
ligands from a combinatorial library to bind to proteins of
interest with high specificity and affinity.
However, the previous approach of solid-phase synth-
esis of γ-AApeptides (Figure 2)24À29 is not suitable for the
development of combinatorial libraries. In this method, a
γ-AApeptide sequence is prepared by assembling γ-AA-
peptide building blocks on solid phase. Each building
block requires a three-step synthesis (reductive amination,
acylation, and deprotection) starting from the correspond-
ing Fmoc-amino aldehyde. For instance, to prepare a
random library of short γ-AApeptides containing three
building blocks (6 side chains, comparable to 6-mer
peptides), with the availability of 10 Fmoc-amino alde-
hydes (R = 10) and 10 carboxylic acids (R = 10), 100
different building blocks have to be generated, which is
almost impossible to achieve.
Figure 1. Representative structure of a native R-peptide and a
γ-AApeptide.
Figure 2. Previous method for the synthesis of γ-AApeptides.
Submonomer approach has been used by many groups
to synthesize different classes of oliogmeric peptido-
mimetics.30À33 To rapidly develop γ-AApeptide libraries,
so as to maximize their biological potential, herein we
report the development of a novel submonomeric ap-
proach for the solid-phase synthesis of short γ-AApeptides
by utilizing an allyl protection. This method circumvents
the necessity of γ-AApeptide building block preparation,
thereby it is expected to greatly facilitate the application of
γ-AApeptides in biomedical sciences in the future.
Indeed, similar to other classes of peptidomimetics,
γ-AApeptides have been shown to be highly resistant to
protease degradation.24 More importantly, they are able to
disrupt proteinÀprotein interactions24 and mimic the Tat
peptide by binding to HIV-1 RNA25 and facilitating
membrane translocation26 with comparable affinity and
efficiency. More recently, we have also demonstrated that
(21) Zuckermann, R. N.; Kodadek, T. Curr. Opin. Mol. Ther. 2009,
11, 299–307.
The new route for the solid-phase synthesis of γ-AApep-
tides using the submonomeric approach is shown in Figure 3.
The first two steps have been used in the microwave-assisted
(22) Astle, J. M.; Simpson, L. S.; Huang, Y.; Reddy, M. M.; Wilson,
R.; Connell, S.; Wilson, J.; Kodadek, T. Chem. Biol. 2010, 17, 38–45.
(23) Goodman, C. M.; Choi, S.; Shandler, S.; DeGrado, W. F. Nat.
Chem. Biol. 2007, 3, 252–262.
(24) Niu, Y.; Hu, Y.; Li, X.; Chen, J.; Cai, J. New J. Chem. 2011, 35,
542–545.
(29) Wu, H.; Niu, Y.; Padhee, S.; Wang, R. E.; Li, Y.; Qiao, Q.; Ge,
B.; Cao, C.; Cai, J. Chem. Sci. 2012, 10.1039/C2SC20428B.
(30) Zuckermann, R. N.; Kerr, J. M.; Kent, S. B. H.; Moos, W. H.
J. Am. Chem. Soc. 1992, 114, 10646–10647.
(31) Hjelmgaard, T.; Faure, S.; Staerk, D.; Taillefumier, C.; Nielsen,
J. Org. Biomol. Chem. 2011, 9, 6832–6843.
(32) Richter, L. S.; Zuckermann, R. N. Bioorg. Med. Chem. Lett.
1995, 5, 1159–1162.
(33) Combs, D. J.; Lokey, R. S. Tetrahedron Lett. 2007, 48, 2679–
2682.
(25) Niu, Y.; Jones, A. J.; Wu, H.; Varani, G.; Cai, J. Org. Biomol.
Chem. 2011, 9, 6604–6609.
(26) Niu, Y.; Bai, G.; Wu, H.; Wang, R. E.; Qiao, Q.; Padhee, S.;
Buzzeo, R.; Cao, C.; Cai, J. Mol. Pharm. 2012, 9, 1529–1534.
(27) Niu, Y.; Padhee, S.; Wu, H.; Bai, G.; Harrington, L.; Burda,
W. N.; Shaw, L. N.; Cao, C.; Cai, J. Chem. Commun. 2011, 47, 12197–
12199.
(28) Niu, Y.; Padhee, S.; Wu, H.; Bai, G.; Qiao, Q.; Hu, Y.;
Harrington, L.; Burda, W. N.; Shaw, L. N.; Cao, C.; Cai, J. J. Med.
Chem. 2012, 55, 4003–4009.
Org. Lett., Vol. 14, No. 13, 2012
3447